chronic migraine headache

^[1]

Introduction

atogepant 30 mg twice a day & 60 mg once a day reduce mean monthly migraine days
- baseline: 19 monthly migraine days
- with atogepant: 12 monthly migraine days
- with placebo: 14 monthly migraine days^[1]

↑ ^1.0 ^1.1 Pozo-Rosich P, Ailani J, Ashina M, et al. Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023 Jul 26:S0140-6736(23)01049-8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/37516125 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01049-8/fulltext